$97.4 Million is the total value of BAM Capital, LLC's 47 reported holdings in Q3 2011. The portfolio turnover from Q2 2011 to Q3 2011 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2011 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2011-11-14
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SEQUENOM INC | May 11, 2009 | 3,122,212 | 5.1% |
| ANTIGENICS INC /DE/ | April 28, 2009 | 6,305,650 | 9.5% |
View BAM Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2011-11-14 |
| 13F-HR | 2011-08-15 |
| 13F-HR | 2011-05-16 |
| 13F-HR | 2011-02-14 |
| 13F-HR | 2010-11-15 |
| 13F-HR | 2010-08-16 |
| 13F-HR | 2010-05-13 |
| 13F-HR | 2010-02-16 |
| 13F-NT | 2009-11-16 |
| 13F-NT | 2009-08-14 |
View BAM Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.